AvenCell Therapeutics

Massachusetts, United States · Biotechnology, Health Care, Medical · 1,000 employees

AvenCell Therapeutics, Inc. is a leading clinical-stage cell therapy company that focuses on advancing autologous and allogeneic switchable CAR-T cell therapies. Their proprietary Universal Switchable CAR-T cell therapy platform is designed to treat various hematologic malignancies and autoimmune diseases. AvenCell aims to transform the standard of care with innovative and adaptable cell therapy t

See plans & pricing → Track AvenCell Therapeutics’s funding, hiring, and signals — with verified contacts — on Fundz.